2nd Annual Pediatric Oncology Integrative Diagnostics and Targeted Therapies Symposium

September 9, 2026 - September 11, 2026
A healthcare professional wearing a face mask and white coat uses a stethoscope to listen to the chest of a child seated on an exam table in a medical room, with diagnostic equipment on the wall and a window showing an outdoor view in the background.

Our second biennial Pediatric Oncology Integrative Diagnostics and Targeted Therapies Symposium, sponsored by the Nationwide Children’s Division of Hematology, Oncology, and Blood & Marrow Transplant, in collaboration with the Institute for Genomic Medicine, will provide a comprehensive overview across three days of current and developing diagnostic and therapeutic approaches. These sessions, anchored by four plenary speakers, will empower pediatric oncology teams to integrate these new tools at each stage of care of children with cancer.

Intended Audience

This conference is designed for Hematology, Oncology, BMT, Neuro-Oncology, Genomic Specialists and Pathologists.

Credits 

AMA PRA Category 1 Credits™ (13.50 hours), ACPE Contact Hour(s) (13.50  hours), ANCC Contact Hour(s) (13.50 hours), APA Credit(s) (13.50 hours), ASWB ACE Credit(s) (13.50 hours), Non-Physician Attendance (13.50 hours)